New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom

by Gazzard, Brian, Moecklinghoff, Christiane, Hill, Andrew
Published 2012

Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials

by Nelson, Mark, Hill, Andrew, van Delft, Yvon, Moecklinghoff, Christiane
Published 2014

The MONET trial: correlation between Hepatitis C coinfection and HIV RNA responses during darunavir/ritonavir monotherapy, for patients with HIV RNA <50 copies/mL at baseline

by Arribas, Jose R, Montes, Maria Luisa, Hill, Andrew, Prakash, Manyu, Moecklinghoff, Christiane
Published 2010

No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogue...

by Solomon, Ajantha, Tennakoon, Surekha, Leeansyah, Edwin, Arribas, Jose, Hill, Andrew, Van Delft, Yvon, Moecklinghoff, Christiane, Lewin, Sharon R.
Published 2014

Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues

by Clarke, Amanda, Johanssen, Veronika, Gerstoft, Jan, Clotet, Bonaventura, Ripamonti, Diego, Murungi, Andrew, Bicer, Ceyhun, Blanca Hadacek, Maria, Moecklinghoff, Christiane
Published 2014

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

by Antinori, Andrea, Arribas, Jose, Fehr, Jan, Girard, Pierre-Marie, Horban, Andrzej, Hill, Andrew, van Delft, Yvon, Moecklinghoff, Christiane, Hill, Andrew
Published 2014